MGC Pharmaceuticals is a drug manufacturers - specialty & generic business based in Australia. MGC Pharmaceuticals shares (MXC) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. MGC Pharmaceuticals has a trailing 12-month revenue of around $3.4 million. If you're looking to buy shares, check out the steps below.
Our top pick for
Low costs
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $0.41 - $13 |
|---|---|
| 50-day moving average | $1.1289 |
| 200-day moving average | $0.2866 |
| Target price | $0.04 |
| PE ratio | 0 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-7.1 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.55
| 1 week (2023-12-01) | -14.06% |
|---|---|
| 1 month (2023-11-09) | -8.33% |
| 3 months (2023-09-08) | -72.50% |
| 6 months (2023-06-09) | -90.83% |
| 1 year (2022-12-09) | -95.42% |
|---|---|
| 2 years (2021-12-09) | -98.59% |
| 3 years (2020-12-09) | -98.43% |
| 5 years (2018-12-07) | -98.66% |
| Revenue TTM | $3.4 million |
|---|---|
| Gross profit TTM | $1.3 million |
| Return on assets TTM | -66.72% |
| Return on equity TTM | -307.4% |
| Profit margin | 0% |
| Book value | -2.209 |
| Market capitalisation | $21.2 million |
TTM: trailing 12 months
We're not expecting MGC Pharmaceuticals to pay a dividend over the next 12 months.
MGC Pharmaceuticals's shares were split on a 1:1000 basis on 30 October 2023. So if you had owned 1000 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your MGC Pharmaceuticals shares – just the quantity. However, indirectly, the new 99900% higher share price could have impacted the market appetite for MGC Pharmaceuticals shares which in turn could have impacted MGC Pharmaceuticals's share price.
Over the last 12 months, MGC Pharmaceuticals's shares have ranged in value from as little as $0.41 up to $13. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while MGC Pharmaceuticals's is 1.054. This would suggest that MGC Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively speaking, a slightly higher risk (but potentially also market-beating returns).
MGC Pharmaceuticals Limited provides phytomedicines worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. In addition, the company provides Irnican that is in preclinical phase for the tetrahydrocannabinol, as well as offers ArtemiC and non-pharma products. Further, it offers consulting services, including clinical research services. MGC Pharmaceuticals Limited was founded in 2014 and is based in Subiaco, Australia.
What you need to know about investing in Shein from Australia.
Looking for the best performing stocks in Australia? We update this list weekly.
If you're thinking of trading stocks with Tiger Brokers, check out our review of this online broker's fees, safety and pros and cons first.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Steps to owning and managing Caltex Australia shares from .
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Learn about the money market and everyday consumer money market products.
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
Follow these tips to find the best share trading platform for you.
